Monocytes/macrophages are thought to play a fundamental role in the development of vascular lesions in atherosclerosis. In the present study, we evaluated circulating CD14 + CD16
Introduction
The progress in therapy accomplished over the last few decades translated into improved survival of patients with different primary tumors. With improved survival or even cure of patients with some forms of metastatic cancer, hitherto unknown and unexpected long-term complications have emerged, including atherosclerosis and associated disorders (1) (2) (3) . Comorbid conditions rather than cancer are commonly the ultimate cause of death in cancer patients (4) . In cancer patients, atherosclerosis with its complications is by far the most important cause of morbidity and mortality due to comorbid disorders. Age, smoking, obesity or oxidative stress all are associated with increased risk of atherosclerosis as well as cancer (5) . Cardiovascular disorders currently represent an important issue in cancer survivors. Several retrospective series now demonstrate that the risk of cardiovascular events, e.g. myocardial infarction, is significantly increased in long-term survivors of testicular cancer or pediatric tumors treated with chemotherapy (1) (2) (3) , and that the toxicity of anticancer therapy may result in the progression of atherosclerosis (6) . However, the data on more common adult tumors are scanty.
Breast cancer is the most common malignant tumor in women (7) . The progress accomplished in the treatment of breast cancer over the last decades is reflected in improved survival. There is now strong evidence that, in addition to early diagnosis, much of the improvement of the prognosis of women with breast cancer results from the use of systemic therapy, such as hormonal treatment and chemotherapy (8) . These treatments of breast cancer may have an important impact on the risk of atherosclerosis (9) . However, in breast cancer survivors both increased and decreased incidence of complications of atherosclerosis has been reported (10, 11) .
Monocytes/macrophages are thought to play a fundamental role in the development of vascular lesions of atherosclerosis. Peripheral blood monocytes are not a homogeneous population, and based on the expression of CD14, C16 and CD56 antigens, at least 5 distinct monocyte populations may be defined. + monocytes further significantly increased during statin therapy that leads to lowering of serum cholesterol (13) . In addition to the search for laboratory parameters of increased risk, e.g. cholesterol, homocysteine or C-reactive protein (CRP) (14) , strategies have been developed for early diagnosis of asymptomatic atherosclerosis.
Measurement of carotid intima-media thickness has been established as an indirect non-invasive test for the detection of coronary atherosclerosis (15) .
Circulating CD14 + CD16 + monocytes are also increased in cancer patients (16) , including patients with breast carcinoma (17) . Neopterin, a heterocyclic compound produced by macrophages after activation with interferon-γ is increased in patients suffering from different disorders, including infections, malignant tumors or atherosclerosis (18) . Increased systemic concentrations of laboratory parameters linked to inflammatory reaction and immune system activation are associated with higher risk of atherosclerosis or its complications (14) . An association with increased risk of complications of atherosclerosis, e.g. coronary artery disease, has also been observed for neopterin (19, 20) . In cancer patients increased neopterin concentrations predict poor prognosis (21, 22) . In patients with breast carcinoma, urinary neopterin concentrations is increased in only about 20% of patients (23, 24) , but increased neopterin is associated with poor prognosis (23) .
In the present study, we evaluated association of circulating CD14 + CD16 + monocytes, serum CRP and urinary neopterin wit laboratory parameters of the risk of atherosclerosis, including serum cholesterol, homocysteine, α-tocopherol and retinol as well as carotid intima-media thickness in patients with breast carcinoma.
Materials and Methods
Thirty-three patients, all females, with histologically verified breast carcinoma were included in the present study. All patients were after primary therapy (surgery and/or chemotherapy or adjuvant external beam radiation). Patients with estrogen and/or progesterone receptor-positive tumors were receiving hormonal therapy (tamoxifen or aromatase inhibitors). The investigations were approved by the institutional ethical committee and the patients signed informed consent.
Blood samples were drawn from a peripheral vein after an overnight fast. The samples were transferred immediately to the laboratory, centrifuged (1600 × g, 10 minutes, 16°C), the serum was separated and either processed immediately (for most parameters) or frozen at -20°C until analysis (for α-tocopherol and retinol).
Peripheral blood cell count was performed as described elsewhere (9) . Hemoglobin was measured by a photometric method using sodium lauryl sulfate, leukocytes and platelets were determined by impedance method using a Sysmex XE-2100 blood analyzer (Sysmex, Kobe, Japan). CD14 + CD16 + monocytes were determined by two-color flow cytometry using fluorescein isothiocyanate-labeled anti-CD14 antibody (Immunotech, Marseille, France) and phycoerythrinlabeled anti-CD16 antibody (Immunotech) on Cytomics FC500 flow cytometer (Beckman Coulter, Hialeah, FL, USA). CRP was determined using particle-enhanced immunoturbidimetric assay, lipoprotein (a) and serum cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides were determined using immunoturbidimetric and enzyme-based assays, respectively, as commercially available on MODULAR analyzer (HoffmannLa Roche, Basel, Switzerland). Homocysteine concentration was determined immunochemically (Immulite 2000, Siemens Healthcare Diagnostics, Deerfield, IL, USA).
Serum α-tocopherol and retinol were determined by high performance liquid chromatography as described (25) . In the liquid-liquid extraction procedure, 500 µL of serum was deproteinized by cool ethanol denatured with 5 % methanol (500 µL, 5 minutes, 4°C). Subsequently, 2 500 µL of n-hexane was added to this mixture and extracted for 5 minutes by a vortex apparatus. After centrifugation (1 600 × g, 10 minutes, 0°C), the aliquot (2 000 µL) of the clean extract was separated and evaporated (45°C) in vacuum concentrator AD 5301 (Eppendorf, Hamburg, Germany). The residue was dissolved in 400 µL of methanol and analyzed by reversed-phase high performance liquid chromatography using the external standard calibration. The analyses were performed using the Perkin Elmer high performance liquid chromatography set (Norwalk, CT, USA) comprising a LC 200 pump, a LC 200 autosampler, LC Column Oven 101 thermostat and LC 235C Diode Array Detector attached to the Perkin Elmer Turbochrom Chromatography Workstation version 4.1. Separation of α-tocopherol and retinol was performed using the Chromolith Performance RP-18e, 100 × 4.6 mm monolithic columns (Merck, Darmstadt, Germany). As the mobile phase 100 % methanol was used at the flow rate of 2.5 mL/min and column pressure 3.3 MPa. The block heater LC Oven 101 (Perkin Elmer) was utilized to keep the analytical column temperature at 25°C. The injection volume was 50 µL. The detection of alphatocopherol and retinol was carried out at 295 nm and at 325 nm, respectively.
Early urine samples were collected and stored at -20°C until analysis. Urinary neopterin was determined using modification of the method described earlier (26) . After centrifugation (5 minutes, 1300 × g) and diluting 100 µL of urine specimens with 1.0 mL of mobile phase containing disodium-EDTA (2 g/L), the samples were filtered using Microtiter, AcroPrep 96 Filter Plate 0.2 m/ 350 µL, Pall Life Science (Ann Arbor, USA) and Vacuum manifold Pall Life Science and then injected onto a column. Neopterin was determined using high performance liquid chromatography system Prominence LC20 (Shimadzu, Kyoto, Japan) composed from Rack changer/C -special autosampler for micro titration plates, Degasser DGU-20A5, 2 Liquid chromatograph Pumps LC-20 AB, Auto sampler SIL-20 AC, Column Over CTO -20 AC Thermostat, Fluorescence detector RF-10 AXL, Diode array detector SPD -M20A and communications bus module CBM-20A. Phosphate buffer 15 mmol/L, pH 6.4, with flow rate 0.8 ml/min was used as mobile phase. Separation was performed using hybrid analytical column Gemini Twin 5µ, C18, 150 × 3 mm (Phenomenex, Torrance, USA) at 25°C, injection volume was 1µl. Neopterin was identified by its native fluorescence (353 nm excitation, 438 nm emission wavelength). Creatinine was monitored simultaneously in the same urine specimen with diode array detector at 235 nm. Time of analysis for urine neopterin and creatinine was 6 minutes and the analytes were quantified by external standard calibration. The neopterin concentrations were expressed as neopterin/creatinine ratio (µmol/mol creatinine). The activity of N-acetyl-β-D-glucosaminidase (NAG) in urine was determined using the method published previously (27) , with minor modifications. NAG activity was expressed as NAG/creatinine ratio (µkat/mol creatinine). The carotid arteries were evaluated with twodimensional imaging using an ultrasound scanner (Aplio, Toshiba, Japan) with a 14-MHz transducer. Intima-media thickness (IMT), defined as the distance between the echogenic line representing blood-intima interface and the echogenic line representing mediaadventitia interface, was measured on the posterior wall of the carotid artery in the longitudinal plane. IMT was evaluated bilaterally at two levels, in the supraclavicular segment of the common carotid artery and 2 cm below bifurcation of the common carotid artery. Three measurements were performed at each level and a mean of these three measurements was calculated. The presence of carotid plaque was noted. The measurements were performed by the same observer.
Correlations were analyzed using Spearman's rank correlation coefficient. The decision on statistical significance was based on p = 0.05 level. The analyses were performed using NCSS software (Number Cruncher Statistical Systems, Kaysville, Utah, USA).
Results
The values of all parameters investigated are shown in Table 1 . The mean total cholesterol and LDL cholesterol concentrations were above the corresponding normal range, but the values of the majority of the other parameters investigated were mostly within normal. Besides obvious correlations between monocyte counts, significant negative correlation was observed between the absolute numbers of CD14 + CD16
+ monocytes and serum HDL cholesterol (Figure 1 ). Absolute 
Discussion
In the present study, correlation was investigated of CD14 + CD16 + monocyte counts with a panel of laboratory parameters indicative of the risk of atherosclerosis, including parameters of lipid metabolism, inflammatory response, antioxidants, renal dysfunction or IMT. In agreement with earlier reports, present data confirm an association between peripheral blood CD14 + CD16 + monocyte counts and lipid concentrations (12, 13, 28) . It is now generally accepted that atherosclerosis is an inflammatory disorder (29) . Systemic inflammatory response resulting from chronic infections that is reflected in increased serum concentrations of CRP has been postulated to play an important role in the progression of atherosclerosis. CRP is increased in both the patients with advanced cancer as well as in patients with atherosclerosis. It has been demonstrated in numerous studies that parameters of systemic inflammatory response, e.g. serum CRP, are predictive of the risk of cardiovascular events (14, (30) (31) (32) . Similar association has been reported for neopterin (19, 20) . Increased neopterin concentrations were demonstrated in patients with acute myocardial infarction (33) , and increased neopterin concentrations are predictive of cardiovascular and all-cause mortality (19, 34) . High neopterin concentrations are also associated with mortality in the elderly (34 + monocytes further increased during statin therapy (13) . In another study, CD14 + CD16 + monocyte number were not different in diabetic patients with and without cardiovascular disease or healthy controls, but the intensity of the expression of CD14 antigen was significantly higher in patients compared to controls (35) . Circulating CD16 
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antigen was found to be increased in patients with coronary artery disease compared to controls, and a positive correlation with LDL cholesterol and negative correlation with HDL cholesterol were observed (36) . Neopterin is an indicator of macrophage activation. In patients with tumors of different primary locations, increased serum or urinary neopterin concentrations were associated with poor prognosis (21, 22) . Correlations were observed between lower numbers or impaired function or phenotype of lymphocytes and dendritic cells, and neopterin concentrations (37) (38) (39) (40) .
No correlation was observed in the present study between urinary neopterin and CD14 + CD16 + monocyte counts or risk factors of atherosclerosis, but the number of subjectes studied was low.
In conclusion, present data extend the observation of an association between peripheral blood CD14 + CD16 + monocyte counts and lipid metabolism to patients with breast cancer. No correlation of CD14 + CD16 + monocyte counts with urinary neopterin concentrations could be observed.
